3,044
Views
0
CrossRef citations to date
0
Altmetric
Editorial

European Dlb Consortium: Diagnostic and Prognostic Biomarkers in Dementia With Lewy Bodies, a Multicenter International Initiative

ORCID Icon, , , , &
Pages 247-250 | Received 16 Aug 2019, Accepted 05 Sep 2019, Published online: 03 Oct 2019

References

  • Vann Jones SA , O’BrienJT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol. Med., 44(4), 673–683 (2014).
  • Kane JPM , SurendranathanA, BentleyAet al. Clinical prevalence of Lewy body dementia. Alzheimers Res. Ther., 10(1), 19 (2018).
  • McKeith IG , DicksonDW, LoweJet al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology, 65(12), 1863–1872 (2005).
  • McKeith I , O’BrienJ, WalkerZet al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a Phase III, multicentre study. Lancet Neurol., 6(4), 305–313 (2007).
  • Yoshita M , AraiH, AraiHet al. Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study. PLoS ONE, 10(3), e0120540 (2015).
  • Galvin JE , DudaJE, KauferDI, LippaCF, TaylorA, ZaritSH. Lewy body dementia: the caregiver experience of clinical care. Parkinsonism Relat. Disord., 16(6), 388–392 (2010).
  • Walker Z , PossinKL, BoeveBF, AarslandD. Lewy body dementias. Lancet, 386, 1683–1697 (2015).
  • Aarsland D , RongveA, NoreSPet al. Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Dementia Geriatric Cog. Disord., 26(5), 445–452 (2008).
  • Zhu CW , ScarmeasN, StavitskyKet al. Comparison of costs of care between patients with Alzheimer’s disease and dementia with Lewy bodies. Alzheimers Dement., 4(4), 280–284 (2008).
  • Mueller C , BallardC, CorbettA, AarslandD. The prognosis of dementia with Lewy bodies. Lancet Neurol., 16(5), 390–398 (2017).
  • Rizzi L , RossetI, Roriz-CruzM. Global epidemiology of dementia: alzheimer’s and vascular types. BioMed Res. Int., 2014, 908915 (2014).
  • Morbelli S , ChincariniA, BrendelMet al. Metabolic patterns across core features in dementia with Lewy bodies. Ann. Neurol., 85(5), 715–725 (2019).
  • Biundo R , WeisL, BostantjopoulouSet al. MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study. J. Neural Transm. (Vienna), 123(4), 431–438 (2016).
  • van Steenoven I , AarslandD, WeintraubDet al. Cerebrospinal fluid Alzheimer’s disease biomarkers across the spectrum of Lewy body diseases: results from a large multicenter cohort. J. Alzheimers Dis., 54(1), 287–295 (2016).
  • Abdelnour C , van SteenovenI, LondosEet al. Alzheimer’s disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia. Mov. Disord., 31(8), 1203–1208 (2016).
  • Kramberger MG , AuestadB, Garcia-PtacekSet al. Long-term cognitive decline in dementia with Lewy bodies in a large multicenter, international cohort. J. Alzheimers Dis., 57(3), 787–795 (2017).
  • Bonanni L , FranciottiR, NobiliFet al. EEG markers of dementia with Lewy bodies: a multicenter cohort study. J. Alzheimers Dis., 54(4), 1649–1657 (2016).
  • Oppedal K , FerreiraD, CavallinLet al. A signature pattern of cortical atrophy in dementia with Lewy bodies: a study on 333 patients from the European DLB consortium. Alzheimers Dement., 15(3), 400–409 (2019).
  • Rongve A , WitoelarA, RuizAet al. GBA and APOE epsilon4 associate with sporadic dementia with Lewy bodies in European genome wide association study. Scientific Reports, 9(1), 7013 (2019).
  • Di Censo R , AbdelnourC, BlancFet al. CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies. J. Neurol. Neurosurg. Psychiatry doi:10.1136/jnnp-2019-320980 (2019) ( Epub ahead of print).
  • Ferreira D , NedelskaZ, AbelnourCet al. Differential impact of amyloid, tau-related pathology, and hippocampal atrophy on the clinical phenotype of DLB: a collaboration between Mayo Clinic DLB Consortium and the European DLB Consortium. Presented at: International Lewy Body Dementia Conference. Las Vegas, NV, USA, 24–26 June 2019.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.